The content on this site is intended for healthcare professionals only
HARMONY - a bench to bedside process
Published: 5 Jan 2018
Views: 1924
Pam Bacon - Celgene
Pam Bacon talks to ecancer at EAPM 2017 in Belfast.
She discusses how Harmony Project should bring drugs to market quicker, as well as the benefits of collaboration.
Related Videos
Momelotinib superior to danazol in symptomatic and anaemic myelofibrosis patient...
Dr Ruben A. Mesa - UT Health San Antonio MD Anderson Cancer Center, San Antonio,...
7 Jun 2022
Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM: Phase 3 D...
Dr Paul Richardson - Dana Farber Cancer Institute, Boston, USA
5 Jun 2022
Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle cel...
Dr Michael Wang - MD Anderson Cancer Center, Houston, USA
4 Jun 2022
The global impact of the FDA's changing approval standards
Dr Bishal Gyawali - Queen's University, Kingston, Canada
2 Feb 2022
Real world evidence on the use of antibody drug conjugates in peripheral T-cell ...
Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut, Leba...
14 Jun 2021
Long term outcome of enfortumab vedotin + pembrolizumab in first line locally ad...
Dr Terence Friedlander - UCSF, San Francisco, USA
4 Jun 2021
Key themes, highlights and importance of this year's IBCD 2020 meeting
Dr Roberto Salgado - Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgiu...
29 Oct 2020
What is global oncology and what is the presence of global oncology in Europe
Prof Cristina Stefan - Institute of Oncology 'Prof Dr Alexandru Trestioreanu', B...
12 Oct 2020
Breast Cancer at ASCO 2020 - AORTIC African Cancer Dialogues
Host: Dr. Miriam Mutebi, Speakers: Dr. Verna Vanderpuye, Dr. Sitna Mwanzi
6 Aug 2020